Abstract
Kuwait has been experiencing a COVID-19 outbreak since the first imported case on Feb 24, 2020. Analysis of data from the early stage of COVID-19 outbreak in Kuwait can provide important information about the potential epidemic and healthcare burdens as well as assist in evaluating the potential impact of various outbreak control measures. Such control measures are essentially implemented to achieve a sufficient reduction in the effective reproduction number during an outbreak. In this study, we use a mathematical modeling framework to simulate the outbreak dynamics of SARS-CoV-2 transmission in Kuwait and forecast the potential burden on the healthcare system. We calibrate the model against daily numbers of detected infection and death cases using a maximum likelihood framework and estimate both the basic and effective reproduction numbers. Our results indicate that the early control measures implemented in Kuwait had the effect of delaying the intensity of the outbreak but were unsuccessful in reducing Rt below 1. This highlights a need for a systematic investigation of the current public health interventions as well as a scientific surveillance tool that is sufficiently sensitive to outbreak temporal dynamics. Meanwhile, the developed model can serve as a public health tool to control the current outbreak and can be used to anticipate effective measures should a second wave re-emerge in Kuwait.
Highlights
Kuwait is experiencing a COVID-19 outbreak since the first imported case on Feb 24, 2020.
We develop a mathematical model of disease transmission to provide a real-time tracking and forecasting tool for the epidemic outbreak in Kuwait as well as assess the potential epidemic and healthcare burdens and the effectiveness of early control measures.
We calibrate the model against daily numbers of detected infection and death cases using a maximum likelihood framework.
We find that early control measures had the effect of delaying and lowering the intensity of the outbreak but were unsuccessful in reducing the effective reproduction number below 1.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for the work presented.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are openly available in [An interactive web-based dashboard to track COVID-19 in real time] at [https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(20)30120-1/fulltext], reference number [3].
